IL134602A0 - Conjugates that contain the homeodomain of antennapedia - Google Patents

Conjugates that contain the homeodomain of antennapedia

Info

Publication number
IL134602A0
IL134602A0 IL13460298A IL13460298A IL134602A0 IL 134602 A0 IL134602 A0 IL 134602A0 IL 13460298 A IL13460298 A IL 13460298A IL 13460298 A IL13460298 A IL 13460298A IL 134602 A0 IL134602 A0 IL 134602A0
Authority
IL
Israel
Prior art keywords
antennapedia
homeodomain
conjugates
contain
Prior art date
Application number
IL13460298A
Other languages
English (en)
Original Assignee
Imp College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imp College Innovations Ltd filed Critical Imp College Innovations Ltd
Publication of IL134602A0 publication Critical patent/IL134602A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43577Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
    • C07K14/43581Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies from Drosophila
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Insects & Arthropods (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Variable-Direction Aerials And Aerial Arrays (AREA)
  • Medicinal Preparation (AREA)
IL13460298A 1997-09-02 1998-09-02 Conjugates that contain the homeodomain of antennapedia IL134602A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9718609.2A GB9718609D0 (en) 1997-09-02 1997-09-02 Fusion protein
PCT/GB1998/002628 WO1999011809A1 (fr) 1997-09-02 1998-09-02 Conjugues renfermant l'homeodomaine de l'antennapedia

Publications (1)

Publication Number Publication Date
IL134602A0 true IL134602A0 (en) 2001-04-30

Family

ID=10818419

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13460298A IL134602A0 (en) 1997-09-02 1998-09-02 Conjugates that contain the homeodomain of antennapedia
IL134602A IL134602A (en) 1997-09-02 2000-02-17 Conjugates that contain the homeodomain of antennapedia

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL134602A IL134602A (en) 1997-09-02 2000-02-17 Conjugates that contain the homeodomain of antennapedia

Country Status (10)

Country Link
US (2) US7968512B2 (fr)
EP (1) EP1009847A1 (fr)
JP (1) JP2001514858A (fr)
AU (1) AU737829B2 (fr)
BR (1) BR9811744A (fr)
CA (1) CA2301157A1 (fr)
GB (1) GB9718609D0 (fr)
IL (2) IL134602A0 (fr)
NZ (1) NZ503007A (fr)
WO (1) WO1999011809A1 (fr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU721121B2 (en) * 1996-12-02 2000-06-22 Wake Forest University Inactivation of HIV co-receptors as therapy for HIV infection
US6221355B1 (en) * 1997-12-10 2001-04-24 Washington University Anti-pathogen system and methods of use thereof
GB9814527D0 (en) * 1998-07-03 1998-09-02 Cyclacel Ltd Delivery system
WO2000027795A1 (fr) 1998-11-12 2000-05-18 Invitrogen Corporation Reactifs de transfection
HUP0204199A3 (en) 1998-11-13 2005-09-28 Cyclacel Ltd Transport vectors
AU762006B2 (en) * 1998-12-24 2003-06-19 Ucb Peptidic product, process and composition
JP2002539839A (ja) * 1999-03-31 2002-11-26 インヴィトロゲン・コーポレーション 転位ポリペプチドによる機能性タンパク質配列の送達
US6773920B1 (en) 1999-03-31 2004-08-10 Invitrogen Corporation Delivery of functional protein sequences by translocating polypeptides
US6372494B1 (en) 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
EP1118668A1 (fr) * 2000-01-07 2001-07-25 ARTEMIS Pharmaceuticals GmbH Transduction d'une recombinase pour le ciblage inductible de gènes
WO2001049832A2 (fr) * 2000-01-07 2001-07-12 Artemis Pharmaceuticals Gmbh Transduction de recombinases pour ciblage genetique inductible
GB0003284D0 (en) * 2000-02-15 2000-04-05 Secr Defence Brit Anti-viral therapy
EP1272221A2 (fr) * 2000-04-12 2003-01-08 Implyx Ltd. Conjugues de peptides utilises pour l'apport de medicament
DE10027777A1 (de) * 2000-06-07 2001-12-13 Otogene Ag Transfektionsverfahren
GB0015090D0 (en) * 2000-06-20 2000-08-09 Implyx Ltd Gene-activating conjugates
KR100374050B1 (ko) * 2000-07-26 2003-03-03 최수영 세포침투성 융합단백질, 이를 코딩하는 재조합폴리뉴클레오타이드 및 발현벡터
US20030027335A1 (en) * 2000-09-07 2003-02-06 Ruley H. Earl Genome engineering by cell-permeable DNA site-specific recombinases
US6472176B2 (en) * 2000-12-14 2002-10-29 Genvec, Inc. Polynucleotide encoding chimeric protein and related vector, cell, and method of expression thereof
US7442686B2 (en) 2001-04-12 2008-10-28 Bioaxone Therapeutique Inc. Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions
CA2367636C (fr) 2001-04-12 2010-05-04 Lisa Mckerracher Proteines de fusion
EP1406573A4 (fr) * 2001-06-07 2005-03-30 Skinmedica Inc Milieu de culture cellulaire conditionne et utilisations de ce milieu
GB0124391D0 (en) * 2001-10-11 2001-11-28 Gene Expression Technologies L Control of gene expression
US20050136040A1 (en) * 2001-10-11 2005-06-23 Imperial College Innovations Limited Control of gene expression using a complex of an oligonucleotide and a regulatory peptide
ITRM20030376A1 (it) 2003-07-31 2005-02-01 Univ Roma Procedimento per l'isolamento e l'espansione di cellule staminali cardiache da biopsia.
US11660317B2 (en) 2004-11-08 2023-05-30 The Johns Hopkins University Compositions comprising cardiosphere-derived cells for use in cell therapy
DE102007041655A1 (de) 2007-09-03 2009-03-05 Medicyte Gmbh Vermehrung von primären Zellen und deren Verwendung
US8119366B2 (en) 2007-10-05 2012-02-21 Trojan Technologies, Ltd. Antennapedia-dominant negative mastermind-like construct
CN102459329A (zh) * 2009-04-14 2012-05-16 特洛伊科技有限公司 治疗性触角足-抗体分子及其使用方法
US9845457B2 (en) 2010-04-30 2017-12-19 Cedars-Sinai Medical Center Maintenance of genomic stability in cultured stem cells
DE102010041958A1 (de) 2010-10-04 2012-04-05 Medicyte Gmbh Geeignete Hepatozyten für in-vitro Genotoxitätstests
US20140296154A1 (en) * 2011-05-06 2014-10-02 Yale University Method of preventing development of psoriatic lesions
US9248198B2 (en) * 2011-06-13 2016-02-02 The Board Of Trustees Of The University Of Illinois Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion
AU2013246034B2 (en) 2012-04-09 2017-12-07 Case Western Reserve University Compositions and methods for inhibiting the activity of LAR family phosphatases
US9884076B2 (en) 2012-06-05 2018-02-06 Capricor, Inc. Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy
US9828603B2 (en) 2012-08-13 2017-11-28 Cedars Sinai Medical Center Exosomes and micro-ribonucleic acids for tissue regeneration
DK3581207T3 (da) 2013-06-11 2023-02-06 Ppl Bvi Ltd Fusionsproteiner omfattende hoxd12 og nemo-bindingsdomæne og anvendelse deraf
EP2927685A1 (fr) 2014-04-02 2015-10-07 Medicyte GmbH Suitable Hepatocytes for in-vitro Hepatitis Tests
EP3169310A1 (fr) 2014-07-15 2017-05-24 Life Technologies Corporation Compositions comprenant des agrégats lipidiques et procédés d'administration efficace de molécules dans des cellules
CA2962444C (fr) 2014-10-03 2023-09-05 Cedars-Sinai Medical Center Cellules derivees de la cardiosphere et exosomes secretes par ces cellules dans le traitement d'une dystrophie musculaire
BR112017018665A2 (pt) 2015-03-02 2018-04-24 The Board Of Trustees Of The University Of Illinois peptídeos para inibição de angiogênese
WO2017123662A1 (fr) 2016-01-11 2017-07-20 Cedars-Sinai Medical Center Cellules dérivées de cardiosphères et exosomes sécrétés par ces cellules dans le traitement d'une insuffisance cardiaque à fraction d'éjection préservée
KR20180132807A (ko) 2016-04-07 2018-12-12 케이스 웨스턴 리저브 유니버시티 신경퇴행성 질환의 치료용 tdp-43 미토콘드리아 국소화 억제제
WO2017210652A1 (fr) 2016-06-03 2017-12-07 Cedars-Sinai Medical Center Exosomes dérivés de cdc pour le traitement des tachyarythmies ventriculaires
US11541078B2 (en) 2016-09-20 2023-01-03 Cedars-Sinai Medical Center Cardiosphere-derived cells and their extracellular vesicles to retard or reverse aging and age-related disorders
WO2018195210A1 (fr) 2017-04-19 2018-10-25 Cedars-Sinai Medical Center Méthodes et compositions pour traiter une dystrophie musculaire squelettique
WO2019126068A1 (fr) 2017-12-20 2019-06-27 Cedars-Sinai Medical Center Vésicules extracellulaires modifiées pour une administration tissulaire améliorée

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2739621B1 (fr) * 1995-10-05 1997-12-05 Centre Nat Rech Scient Peptides utilisables comme vecteurs pour l'adressage intracellulaire de molecules actives

Also Published As

Publication number Publication date
AU8877698A (en) 1999-03-22
US8735340B2 (en) 2014-05-27
JP2001514858A (ja) 2001-09-18
US20110256168A1 (en) 2011-10-20
AU737829B2 (en) 2001-08-30
IL134602A (en) 2006-10-31
US20080317773A1 (en) 2008-12-25
GB9718609D0 (en) 1997-11-05
CA2301157A1 (fr) 1999-03-11
EP1009847A1 (fr) 2000-06-21
BR9811744A (pt) 2002-01-02
WO1999011809A1 (fr) 1999-03-11
US7968512B2 (en) 2011-06-28
NZ503007A (en) 2000-11-24

Similar Documents

Publication Publication Date Title
IL134602A0 (en) Conjugates that contain the homeodomain of antennapedia
GB9713980D0 (en) New conjugates
TJ328B (en) Interferron conjugates
AU3648399A (en) Terminally-branched polymeric linkers and polymeric conjugates containing the same
GB2329490B (en) Remote application design
PL334708A1 (en) Readucing union piece
AU6181298A (en) Combination mechanical rotator-rocker
GB9704776D0 (en) Detergent - packaging combination
GB9705787D0 (en) Modified dendroaspins
GB9704112D0 (en) The Sandelver
GB9716887D0 (en) Translation
ZA985760B (en) Glass composition of the silica-soda-lime-type
TW396962U (en) Mechanical pencil
EP0935608A4 (fr) Peptides cytotoxiques
TW389171U (en) Mechanical pencil
TW356768U (en) Double-chuck type mechanical pencil
GB9721880D0 (en) The body box
AU129822S (en) Flag
AU133015S (en) Flag
AU132890S (en) Flag
AU134978S (en) Flag
AU131747S (en) Flag
GB9716429D0 (en) The other option
GB9702705D0 (en) The easi-over
GB9705157D0 (en) The micropager

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed